CanCuRX Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • 2ndary - Private

CanCuRX General Information

Description

Developer of a novel treatment intended to cure pancreatic cancer. The company utilizes the properties of a mushroom-derived compound that arrests pancreatic cell growth, enabling cancer patients to survive the disease.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Corporate Office
  • Eshkol Tower
  • University of Haifa
  • Haifa 3498838
  • Israel
Primary Industry
Biotechnology
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • Eshkol Tower
  • University of Haifa
  • Haifa 3498838
  • Israel

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

CanCuRX Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Secondary Transaction - Private Completed Startup
1. Seed Round Completed Startup
To view CanCuRX’s complete valuation and funding history, request access »

Ready to get started?

Request a free trial

CanCuRX FAQs

  • When was CanCuRX founded?

    CanCuRX was founded in 2016.

  • Where is CanCuRX headquartered?

    CanCuRX is headquartered in Haifa, Israel.

  • What industry is CanCuRX in?

    CanCuRX’s primary industry is Biotechnology.

  • Is CanCuRX a private or public company?

    CanCuRX is a Private company.

  • What is CanCuRX’s current revenue?

    The current revenue for CanCuRX is .

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process